U.S. Food and Drug Administration Corporate Counsel Salaries in Gulfport-Biloxi, MS
The average U.S. Food and Drug Administration Corporate Counsel in Gulfport-Biloxi, MS earns an estimated $195,163 annually, which includes an estimated base salary of $162,840 with a $32,323 bonus. U.S. Food and Drug Administration's Corporate Counsel compensation is $16,819 more than the US average for a Corporate Counsel. Corporate Counsel salaries at U.S. Food and Drug Administration in Gulfport-Biloxi, MS can range from $93,000 - $370,000.
In Gulfport-Biloxi, MS, The Legal Department at U.S. Food and Drug Administration earns $12,713 more on average than the Business Development Department.
Last updated 3 years ago.
- $162,840
- avg. base
- $32,323
- avg. bonus
Corporate Counsel Salaries at U.S. Food and Drug Administration
In Gulfport-Biloxi, MS, Corporate Counsels earn $4,596 more than Corporate Counsels, and $10,648 less than General Counsels.
Compensation at U.S. Food and Drug Administration by Department
In Gulfport-Biloxi, MS, The Legal Department averages $12,713 more than the Business Development Department, and $2,217 less than the Product Department
Corporate Counsel Compensation by Gender (All Companies)
The average female Corporate Counsel at companies similar size to U.S. Food and Drug Administration reported making $190,419, while the average male Corporate Counsel at similar sized companies reported making $218,835.
Corporate Counsel Compensation by Ethnicity (All Companies)
The average Caucasian Corporate Counsel at companies similar size to U.S. Food and Drug Administration reported making $215,700, while the average Asian or Pacific Islander Corporate Counsel at similar sized companies reported making $176,738.
How Corporate Counsels at U.S. Food and Drug Administration Rate Their Compensation
The majority of Corporate Counsels at U.S. Food and Drug Administration believe they're compensated fairly. 100% of Corporate Counsels at U.S. Food and Drug Administration say they receive annual bonuses, and the vast majority (71%) are satisfied with their benefits. See more compensation ratings at U.S. Food and Drug Administration
